[ad_1]
The Drug Enforcement Administration reprogrammed Epidiolex, paving the way for GW Pharmaceuticals to sell the first FDA-approved drug derived from cannabis, but not allowing reclassification of all cannabidiol-based products.
Source link
[ad_1]
The Drug Enforcement Administration reprogrammed Epidiolex, paving the way for GW Pharmaceuticals to sell the first FDA-approved drug derived from cannabis, but not allowing reclassification of all cannabidiol-based products.
Source link
Tags allowing DEA Drug Epidiolex GW Pharma plans selling Start
